Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, August 30 '25)

Image
By G.M.

 


    Arch Virol

  1. HU Y, Hu C, Su J, Zhu B, et al
    Two cross-neutralizing antibodies isolated from a COVID-19 convalescent via single B cell sorting.
    Arch Virol. 2025;170:199.
    PubMed         Abstract available


    Biochemistry

  2. ADEWOYE A, Ezeigbo E, Vo QH, Legleiter J, et al
    Amyloidogenic SARS-CoV-2 Spike Protein-Derived Peptides Form Oligomers and Selectively Damage Lipid Membranes.
    Biochemistry. 2025;64:3610-3622.
    PubMed         Abstract available


    Epidemiol Infect

  3. PARRADO R, Cuba-Grandy CX, Fuentes-Luppichini E, Torrico Villarroel NG, et al
    Multiplex RT-qPCR strategy for SARS-CoV-2 variants detection in developing countries without ngs: The Bolivian experience.
    Epidemiol Infect. 2025;153:e94.
    PubMed         Abstract available

  4. BUBAR K, Middleton C, Larremore D, Gostic K, et al
    A fundamental limit to the effectiveness of traveller screening with molecular tests.
    Epidemiol Infect. 2025;153:e95.
    PubMed         Abstract available


    J Clin Microbiol

  5. XUE YC, Bertsch J, Monacy K, Haynes C, et al
    Enhancing diagnostic preparedness for H5N1: a validation study of H5 single-plex assay and detection across multiple platforms.
    J Clin Microbiol. 2025;63:e0068125.
    PubMed         Abstract available


    J Immunol

  6. FENG Z, Han S, He Q, Zhao H, et al
    Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-gamma response, and T-cell functions during respiratory syncytial virus infection.
    J Immunol. 2025;214:1982-1999.
    PubMed         Abstract available


    J Infect

  7. CHRISTIANSEN CH, Sogaard KK, Dam-Dalgeir G, Dessau RB, et al
    Surveillance of invasive beta-haemolytic streptococci in Denmark, 2012 to 2023: A nationwide study.
    J Infect. 2025 Jul 24:106559. doi: 10.1016/j.jinf.2025.106559.
    PubMed         Abstract available

  8. KALKERI R, Zhu M, Cloney-Clark S, Parekh A, et al
    Anti-Spike IgG4 and Fc Effector Responses: The Impact of SARS-CoV-2 Vaccine Platform-Specific Priming and Immune Imprinting.
    J Infect. 2025 Jun 26:106543. doi: 10.1016/j.jinf.2025.106543.
    PubMed         Abstract available


    J Virol

  9. GUO Y, Shu S, Zhou Y, Peng W, et al
    An emerging PB2-627 polymorphism increases the zoonotic risk of avian influenza virus by overcoming ANP32 host restriction in mammalian and avian hosts.
    J Virol. 2025 Aug 27:e0085325. doi: 10.1128/jvi.00853.
    PubMed         Abstract available

  10. GUO Z, Banas VS, He Y, Weiland E, et al
    Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin.
    J Virol. 2025 Aug 29:e0068525. doi: 10.1128/jvi.00685.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  11. MOULIA DL, Link-Gelles R, Chu HY, Jamieson D, et al
    Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:508-514.
    PubMed         Abstract available

  12. GROHSKOPF LA, Blanton LH, Ferdinands JM, Reed C, et al
    Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:500-507.
    PubMed         Abstract available


    PLoS One

  13. HAMDY A, Youssef A, Ryan C
    Arab2Vec: An Arabic word embedding model for use in Twitter NLP applications.
    PLoS One. 2025;20:e0328369.
    PubMed         Abstract available

  14. YANG C, Li J, Zeng Q, Feng X, et al
    Social support and risk perception of influenza among Chengdu residents: A cross-sectional study during post-pandemic recovery.
    PLoS One. 2025;20:e0331052.
    PubMed         Abstract available

  15. PUGGINA A, Marijam A, Cailloux O, Vicentini M, et al
    Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy.
    PLoS One. 2025;20:e0330763.
    PubMed         Abstract available

  16. BIRHANU N, Mamo G, Shiferaw GS, Gizachew D, et al
    Factors affecting diabetes related hospitalization and in-hospital outcomes of adults with diabetes in south Ethiopia: A prospective observational study.
    PLoS One. 2025;20:e0330735.
    PubMed         Abstract available

  17. BASKIN RG, Copel LC, Mensinger JL, Brom H, et al
    Nurse resilience, burnout, pandemic stress, and post-traumatic stress: A secondary analysis of a longitudinal cohort.
    PLoS One. 2025;20:e0328976.
    PubMed         Abstract available

  18. MEULE A, Kroll D, Bonsch M, Schneeberger T, et al
    Mental and physical health in persons receiving inpatient pulmonary rehabilitation treatment for post-COVID condition.
    PLoS One. 2025;20:e0330938.
    PubMed         Abstract available

  19. GAN Z, Fu Z, Dong P, Ju Y, et al
    Computational modeling and analysis of medical resource shortages in hospital alliance: A simulation-driven approach.
    PLoS One. 2025;20:e0330871.
    PubMed         Abstract available

  20. SMIT T, Carstens G, Han W, Bulsink K, et al
    Flexible and scalable participatory syndromic and virological surveillance for respiratory infections: Our experiences in The Netherlands.
    PLoS One. 2025;20:e0303230.
    PubMed         Abstract available

  21. ABUHAMMAD S, Alzoubi KH, Khabour OF, Hamaideh S, et al
    Physical and mental health well-being of COVID-19 recovered patients: A phenomenological study.
    PLoS One. 2025;20:e0324433.
    PubMed         Abstract available

  22. BRADLEY J, Tang F, Resendes NM, Tosi DM, et al
    Lower cancer incidence three years after COVID-19 infection in a large veteran population.
    PLoS One. 2025;20:e0318131.
    PubMed         Abstract available

  23. BRYAN SP, Zand MS
    Future Sequon Finder - A novel approach for predicting future N-linked glycosylation sequon locations on viral surface proteins.
    PLoS One. 2025;20:e0328174.
    PubMed         Abstract available

  24. LEE Y, Qin C, Lee M, Deng J, et al
    Korean and Chinese citizens' pandemic fatigue and related factors amidst the prolonged COVID-19 pandemic: Implications for risk communication.
    PLoS One. 2025;20:e0329262.
    PubMed         Abstract available

  25. MARTINEZ-CAJAS JL, Alvarado B, Jolly A, Gong Y, et al
    SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE).
    PLoS One. 2025;20:e0303813.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A


  26. Correction for Soni et al., BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.
    Proc Natl Acad Sci U S A. 2025;122:e2521789122.
    PubMed        

  27. LI Y, Wang Z, Wang J, Jiang Z, et al
    ARRDC4-mediated glycolysis enhances innate immunity to influenza A virus through fructose-1,6-bisphosphate.
    Proc Natl Acad Sci U S A. 2025;122:e2512385122.
    PubMed         Abstract available

  28. WAN Z, Li C, Zhou Y, Yu Y, et al
    Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy.
    Proc Natl Acad Sci U S A. 2025;122:e2509616122.
    PubMed         Abstract available

  29. VICARY AC, Jordan SNZ, Mendes M, Swaminath S, et al
    CRISPR with Transcriptional Readout reveals influenza transcription is modulated by NELF and can precipitate an interferon response.
    Proc Natl Acad Sci U S A. 2025;122:e2515564122.
    PubMed         Abstract available

  30. MARKOWITZ DM, Mazzuchi T, Syropoulos S, Law KF, et al
    An exploration of basic human values in 38 million obituaries over 30 years.
    Proc Natl Acad Sci U S A. 2025;122:e2510318122.
    PubMed         Abstract available


    Vaccine

  31. COSTELLO LM, Kerns EK, McCulloh RJ, Roberts JR, et al
    Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children.
    Vaccine. 2025;61:127245.
    PubMed         Abstract available

  32. HALONEN A, Fan HSL, Masina S, Chooniedass R, et al
    Understanding COVID-19 vaccine hesitancy during parenthood in British Columbia.
    Vaccine. 2025;61:127305.
    PubMed         Abstract available

  33. HU XX, Qin ZZ, Mo ZY, Wang R, et al
    Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages.
    Vaccine. 2025;61:127346.
    PubMed         Abstract available

  34. GAO RY, Hu T, Taylor AW, Lacey R, et al
    Assay for rapid quantification of capped and tailed intact mRNA.
    Vaccine. 2025;61:127339.
    PubMed         Abstract available

  35. WAN JIA AARON H, Yuan R, Chan SCS
    Socio-demographic and behavioral predictors of multiple-dose COVID-19 vaccine uptake among older adults in Hong Kong: A community-based cross-sectional study of the generations connect project.
    Vaccine. 2025;61:127308.
    PubMed         Abstract available

  36. SAYEM ASM, Musuka G, Atuhebwe PL, Dadari I, et al
    Childhood vaccination catch-up and recovery plans for mitigating immunity gap post the COVID-19 pandemic: A case study of selected African countries.
    Vaccine. 2025;61:127328.
    PubMed         Abstract available

  37. HARTON PE, Chamberlain AT, Moore A, Fletcher G, et al
    Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program.
    Vaccine. 2025;61:127292.
    PubMed         Abstract available

  38. MA M, Zou J, Zeng X, Hu X, et al
    Bivalent fusion protein vaccine induces protective immunity against SARS-CoV-2 and Staphylococcus aureus.
    Vaccine. 2025;61:127411.
    PubMed         Abstract available

  39. SIDDIQI DA, Iftikhar S, Anfossi CM, Siddique M, et al
    Assessing the impact of heat waves on childhood immunization coverage in Sindh, Pakistan: Insights from 132.4 million doses recorded in the provincial electronic immunization registry (2018-2024).
    Vaccine. 2025;61:127424.
    PubMed         Abstract available

  40. MACHIDA M, Inoue S, Furuse Y, Oka E, et al
    Exploring the knowledge and attitude toward respiratory syncytial virus vaccine and associated factors among pregnant women in Japan during the early post-marketing phase.
    Vaccine. 2025;61:127434.
    PubMed         Abstract available

  41. CENAT JM, Beogo I, Dalexis RD, Muray M, et al
    Racial disparities in the rates of COVID-19 vaccine uptake among children from Arab, Asian, Black, Indigenous, White and Mixed racial families in Canada.
    Vaccine. 2025;61:127421.
    PubMed         Abstract available

  42. MCDONALD JU, Hosken NA, Engelhardt OG
    Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus.
    Vaccine. 2025;61:127430.
    PubMed         Abstract available

  43. FREITAS C, Cooper CL, Kroch AE, Moineddin R, et al
    COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada.
    Vaccine. 2025;61:127422.
    PubMed         Abstract available

  44. WILTON J, Velasquez Garcia HA, Naveed Z, Crabtree A, et al
    COVID-19 vaccine uptake and effectiveness among people with recent history of injection drug use in British Columbia, Canada: A retrospective analysis.
    Vaccine. 2025;61:127423.
    PubMed         Abstract available

  45. VASILEV K, Puente-Massaguer E, Hoxie I, Bushfield K, et al
    Innate and T-cellular immune responses to sequential vaccination with chimeric hemagglutinin split influenza virus vaccines in mice.
    Vaccine. 2025;63:127626.
    PubMed         Abstract available

  46. BELLER NS, Beller M, Murmann JJ, Crisp RW, et al
    Impact of the medical briefing and vaccine type on adverse events following COVID-19 vaccination: A randomized clinical trial.
    Vaccine. 2025;61:127392.
    PubMed         Abstract available

  47. TONG S, Litwin SM, Epel ES, Lin J, et al
    COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response.
    Vaccine. 2025;61:127420.
    PubMed         Abstract available

  48. TSENG WP, Wu JL, Lin CH, Kang CM, et al
    Safety, immunogenicity, and breakthrough infection of nine homologous or heterologous COVID-19 vaccination booster regimens in healthy adults: A prospective study in Taiwan.
    Vaccine. 2025;61:127383.
    PubMed         Abstract available

  49. PATZINA A, Trubner M, Lehmann J, Brinkhaus B, et al
    Attitudes towards conventional and non-conventional medical approaches and their relation to COVID-19 vaccination: Insights from Germany.
    Vaccine. 2025;61:127403.
    PubMed         Abstract available

  50. JWA S, Imanishi Y, Ascher MT, Dudley MZ, et al
    Communication interventions to reduce parental vaccine hesitancy: A systematic review.
    Vaccine. 2025;61:127401.
    PubMed         Abstract available

  51. CHAULAGAIN S, Sachithanandham J, Liu JA, Creisher PS, et al
    COVID-19 vaccine (NVX-CoV2373 and NVX-CoV2540) doses and virus strain match impact sex- and age-specific immunity and protection in mice.
    Vaccine. 2025;61:127409.
    PubMed         Abstract available

  52. REYBURN R, Russell FM, Munywoki PK, Franzel L, et al
    Designing effectiveness and impact studies for respiratory syncytial virus immunisation in low- and middle-income countries.
    Vaccine. 2025;61:127397.
    PubMed         Abstract available

  53. MUSTAJAB T, Kwamboka MS, Khan I, Song D, et al
    Immunologic responses to an extracellular vesicle-based vaccine expressing the full suite of SARS-CoV-2 structural proteins.
    Vaccine. 2025;61:127407.
    PubMed         Abstract available

  54. PURCELL RA, Aurelia LC, Allen LF, Bond KA, et al
    Genetic markers of enhanced functional antibody responses to COVID-19 vaccination.
    Vaccine. 2025;61:127379.
    PubMed         Abstract available

  55. BEZELJAK U, Jerman A, Kobal T, Birsa E, et al
    Development of multivalent SARS-CoV-2 virus-like particle vaccine candidates.
    Vaccine. 2025;61:127394.
    PubMed         Abstract available

  56. SCHUTT CR, Birol D, Lu X, Yamasaki S, et al
    The presenting HLA determines fidelity of SARS-CoV-2 spike protein epitope prediction.
    Vaccine. 2025;61:127381.
    PubMed         Abstract available

  57. FAWOLE A, Boyer B, Shahid M, Bharali I, et al
    What are the key features of an equitable global vaccine strategy for the next pandemic? A qualitative study of pandemic control experts.
    Vaccine. 2025;61:127377.
    PubMed         Abstract available

  58. WANG Y, Lu G
    Global, regional, and national epidemiology of pertussis in children from 1990 to 2021.
    Vaccine. 2025;61:127378.
    PubMed         Abstract available

  59. TSCHERNE A, Krammer F
    A review of currently licensed mucosal COVID-19 vaccines.
    Vaccine. 2025;61:127356.
    PubMed         Abstract available

  60. KIM SH, You SH, Lee JW, Kim E, et al
    Association between COVID-19 vaccination and first healthcare utilization for chronic obstructive pulmonary disease: A nationwide population-based cohort study.
    Vaccine. 2025;61:127367.
    PubMed         Abstract available

  61. ANEZ G, McGarry A, Woo W, Kotloff KL, et al
    Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19).
    Vaccine. 2025;61:127362.
    PubMed         Abstract available

  62. ARCOLACI A, Guidolin L, Olivieri E, Bilo MB, et al
    A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccines.
    Vaccine. 2025;61:127337.
    PubMed         Abstract available

  63. MOSHIRIAN FARAHI SMM, Xu Y, Dort J, Caulley L, et al
    Factors associated with COVID-19 vaccine confidence among Arab, Asian, Black, Indigenous, and White individuals in Canada: Latent profile analyses.
    Vaccine. 2025;61:127358.
    PubMed         Abstract available

  64. CHAIWONG W, Takheaw N, Laopajon W, Nisoong C, et al
    Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics.
    Vaccine. 2025;61:127330.
    PubMed         Abstract available

  65. MOHAMMADI S, Sisay MM, Saraswati PW, Osman AK, et al
    COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials.
    Vaccine. 2025;61:127342.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »